Sandra Sanders‐van Wijk

Author

Also Known As

Nasser Davarzani, S. Sanders-Van Wijk, S. Sanders-van Wijk, Sanders-Van Wijk, S., Sandra S van Wijk, Sandra Sanders-Van Wijk, Sandra Sanders-van Wijk, Sandra Sanders‐van Wijk, Sandra Sanders–van Wijk

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Maastricht University Maastricht University Medical Centre Kantonsspital St. Gallen University Hospital of Basel Zuyderland Medisch Centrum

About

Sandra Sanders‐van Wijk is an author at Maastricht University specializing in medicine, heart failure, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	276
2	Public Health	3	3	63
3	Health Sciences	1	1	15
4	Biostatistics	1	1	30
5	Cardiothoracic Surgery	1	1	53

Sandra Sanders‐van Wijk

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Circulating Biomarkers of Distinct Pathophysiological Pathways in Heart Failure with Preserved vs. Reduced Left Ventricular Ejection Fraction Sandra Sanders‐van Wijk, Vanessa van Empel, Nasser Davarzani, European Journal of Heart Failure	2015	253
Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure With Preserved Ejection Fraction Sandra Sanders‐van Wijk, Jasper Tromp, Lauren Beussink‐Nelson, Circulation	2020	251
Validation of the HFA-PEFF Score for the Diagnosis of Heart Failure with Preserved Ejection Fraction Arantxa Barandiarán Aizpurua, Sandra Sanders‐van Wijk, Hans‐Peter Brunner‐La Rocca, European Journal of Heart Failure	2019	163
Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: Eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis Mark R. Hazebroek, Michael J. Kemna, Simon Schalla, International Journal of Cardiology Autoimmune DiseaseVasculitisHematologyImmunologyPathology	2015	140
Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy Job A.J. Verdonschot, Mark R. Hazebroek, Ping Wang, Circulation Heart Failure	2018	93
Osteoglycin Prevents Cardiac Dilatation and Dysfunction After Myocardial Infarction Through Infarct Collagen Strengthening Lucas Van Aelst, Sandra Voss, Paolo Carai, Circulation Research	2014	88
Cost-Effectiveness of N-Terminal Pro-B-Type Natriuretic-Guided Therapy in Elderly Heart Failure Patients Sandra Sanders‐van Wijk, Antoinette D. I. van Asselt, Hans Rickli, JACC Heart Failure Heart FailureCardiovascular DiseaseGeriatricsOutcomes ResearchCardiac Care	2013	53
Polygenic Score for β-Blocker Survival Benefit in European Ancestry Patients With Reduced Ejection Fraction Heart Failure David E. Lanfear, Jasmine A. Luzum, Ruicong She, Circulation Heart Failure	2020	41
Long-Term Results of Intensified, N-Terminal-Pro-B-Type Natriuretic Peptide–Guided Versus Symptom-Guided Treatment in Elderly Patients With Heart Failure Sandra Sanders‐van Wijk, Micha T. Maeder, Fabian Nietlispach, Circulation Heart Failure	2013	38
Multimarker Strategy for Short-Term Risk Assessment in Patients With Dyspnea in the Emergency Department Luc W.M. Eurlings, Sandra Sanders‐van Wijk, Roland van Kimmenade, Journal of the American College of Cardiology Prognostic EvaluationDisease Risk AssessmentMedicinePatient SafetyDiagnosis	2012	35

Page 1